Being prone for a narrow therapeutic window
, small changes in warfarin concentrations for example due to codispensed drugs, may lead to an increased or decreased anticoagulation, potentially with devastating consequences.
By rendering healthy blood and bone marrow cells 'invisible' to CD33-targeted therapies, VOR33 aims to significantly improve the therapeutic window
and effectiveness of these AML therapies with potential to broaden clinical benefit to different patient populations.
Targeting of the inhibitor enzyme Notum may provide a new way to increase the therapeutic window
and to promote recovery in societies with the aging population.
Harrison believes Sarepta has a "broad therapeutic window
" and should now take majority market share.
Comparative Evaluation of Therapeutic Window
to Thrombolysis and Time to Pain Relief in The Study Group and the Control Group Mean [+ or -] Standard Deviation Therapeutic Window
Time to Pain Relief after Subjects (Hours) STK (Hours) Study group 6.32 [+ or -] 2.23 5.90 [+ or -] 4.76 Control group 4.90 [+ or -] 1.96 5.61 [+ or -] 3.36 Table 8.
Endolysin technology opens a new therapeutic window
for treatment of chronic inflammatory conditions, atopic dermatitis and persistent wound infections, including those caused by MRSA.
AAV-based gene therapy is a promising therapeutic option for treating deafness but its application is limited by a potentially narrow therapeutic window
. In humans, inner ear development is completed in utero and hearing becomes possible at approximately 20 weeks of gestation.
His impression was "right hemisphere cerebral infarct, likely basal ganglia location." By this time, however, the plaintiff was outside the therapeutic window
for administration of tissue plasminogen activator (tPA), an anticoagulant used to treat blood clots.
The problem, Greeno said, is that chemotherapy drugs can have a very narrow therapeutic window
and often cost between $10,000 and $20,000 per month.
(1) was well-designed and adequately performed, the exciting results may put amantadine at the risk of being labelled as a 'miracle drug' before appropriate information on its biological action, underlying mechanism and therapeutic window
is assessed, similar to the cases of other drugs previously investigated as neuroprotectants (4).
It is clear from available clinical and preclinical evidence that moderate therapeutic hypothermia should be implemented in this therapeutic window
period, before onset of secondary injury and continued until this period of secondary energy failure has resolved.